Tim Ahfeldt

9.3k total citations · 2 hit papers
22 papers, 5.0k citations indexed

About

Tim Ahfeldt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Tim Ahfeldt has authored 22 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Tim Ahfeldt's work include Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Tim Ahfeldt is often cited by papers focused on Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (9 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Tim Ahfeldt collaborates with scholars based in United States, Germany and Japan. Tim Ahfeldt's co-authors include Chad A. Cowan, George Q. Daley, Konrad Hochedlinger, Nimet Maherali, M. William Lensch, Natasha Arora, Akiko Shimamura, Hongguang Huo, In-Hyun Park and Frank H. Lau and has published in prestigious journals such as Cell, Nature Communications and Nature Genetics.

In The Last Decade

Tim Ahfeldt

21 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA

2010 1.9k citations Tim Ahfeldt, Frank H. Lau et al. Cell stem cell profile →
Disease-Specific Induced Pluripotent Stem Cells

2008 1.6k citations In-Hyun Park, Natasha Arora et al. Cell profile →

Peers

Countries citing papers authored by Tim Ahfeldt

Since Specialization

Citations

This map shows the geographic impact of Tim Ahfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Ahfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Ahfeldt more than expected).

Fields of papers citing papers by Tim Ahfeldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Ahfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Ahfeldt. The network helps show where Tim Ahfeldt may publish in the future.

Co-authorship network of co-authors of Tim Ahfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Ahfeldt. A scholar is included among the top collaborators of Tim Ahfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Ahfeldt. Tim Ahfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model 2024 ·Nature Communications ·Gustavo Morrone Parfitt, Elena Coccia, (unknown), Kristen Whitney, (unknown), Lily Sarrafha, Ki Hong Nam, (unknown), Drew R. Jones, John F. Crary, Alban Ordureau, Joel Blanchard, Tim Ahfeldt	26
2	Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease 2024 ·Science Advances ·Qian Wang, Minghui Wang, Insup Choi, Lily Sarrafha, M H Liang, Lap Ho, Kurt Farrell, Kristin G. Beaumont, Robert Sebra, Claudia De Sanctis, John F. Crary, Tim Ahfeldt, Joel Blanchard, Drew Neavin, Joseph E. Powell, David A. Davis, Xiaoyan Sun, Bin Zhang, Zhenyu Yue	28
3	Generating a novel and reliable human iPSC‐derived midbrain organoid model of sporadic progressive supranuclear palsy 2024 ·Alzheimer s & Dementia ·(unknown), Kristen Whitney, (unknown), (unknown), Claudia De Sanctis, (unknown), (unknown), (unknown), Kurt Farrell, (unknown), Megan A. Iida, Lily Sarrafha, Gustavo Morrone Parfitt, Ruth H. Walker, Melissa J. Nirenberg, Giulietta Riboldi, Steven J. Frucht, Tim Ahfeldt, Sally Temple, John F. Crary	0
4	A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides 2023 ·Nature Communications ·Kimberly C. Paul, Richard C. Krolewski, Edinson Lucumi Moreno, (unknown), Kristina M. Holton, Tim Ahfeldt, Melissa Furlong, Yu Yu, Myles Cockburn, Laura Thompson, Alexander Kreymerman, (unknown), (unknown), (unknown), Richard Lee, Jeff M. Bronstein, Lee L. Rubin, Vikram Khurana, Beate Ritz	50
5	Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity 2023 ·iScience ·Lily Sarrafha, Drew Neavin, Gustavo Morrone Parfitt, Ilya Kruglikov, Kristen Whitney, (unknown), Elena Coccia, Tatyana Kareva, (unknown), (unknown), Gist F. Croft, John F. Crary, Joseph E. Powell, Joel Blanchard, Tim Ahfeldt	9
6	Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy 2021 ·Molecular Cell ·Alban Ordureau, Felix Kraus, Jiuchun Zhang, Heeseon An, Sookhee Park, Tim Ahfeldt, João A. Paulo, J. Wade Harper	63
7	High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells 2021 ·STAR Protocols ·Lily Sarrafha, Gustavo Morrone Parfitt, (unknown), (unknown), Elena Coccia, Tatyana Kareva, Tim Ahfeldt	11
8	Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease 2021 ·Stem Cell Research & Therapy ·Elena Coccia, Tim Ahfeldt	10
9	Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons 2020 ·Stem Cell Reports ·Tim Ahfeldt, Alban Ordureau, Christina Bell, Lily Sarrafha, Chicheng Sun, Silvia Piccinotti, (unknown), Gustavo Morrone Parfitt, João A. Paulo, (unknown), Takayuki Uozumi, Yasujiro Kiyota, J. Wade Harper, Lee L. Rubin	37
10	Modeling the complex genetic architectures of brain disease 2020 ·Nature Genetics ·Michael B. Fernando, Tim Ahfeldt, Kristen Brennand	29
11	Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics 2018 ·Molecular Cell ·Alban Ordureau, João A. Paulo, Wei Zhang, Tim Ahfeldt, Jiuchun Zhang, (unknown), Zhonggang Hou, Jin‐Mi Heo, Lee L. Rubin, Sachdev S. Sidhu, Steven P. Gygi, J. Wade Harper	138
12	Studying human disease using human neurons 2016 ·Brain Research ·Tim Ahfeldt, Nadia K. Litterman, Lee L. Rubin	10
13	Generation of Multipotent Lung and Airway Progenitors from Mouse ESCs and Patient-Specific Cystic Fibrosis iPSCs 2012 ·Cell stem cell ·Hongmei Mou, Rui Zhao, Richard J. Sherwood, Tim Ahfeldt, Allen Lapey, John Wain, Leonard Sicilian, Konstantin I. Izvolsky, Kiran Musunuru, Chad A. Cowan, Jayaraj Rajagopal	5
14	Generation of Multipotent Lung and Airway Progenitors from Mouse ESCs and Patient-Specific Cystic Fibrosis iPSCs 2012 ·Cell stem cell ·Hongmei Mou, Rui Zhao, Richard I. Sherwood, Tim Ahfeldt, Allen Lapey, John Wain, Leonard Sicilian, Konstantin I. Izvolsky, Frank H. Lau, (unknown), Chad A. Cowan, Jayaraj Rajagopal	226
15	Pattern Specification and Immune Response Transcriptional Signatures of Pericardial and Subcutaneous Adipose Tissue 2011 ·PLoS ONE ·Frank H. Lau, Rahul C. Deo, (unknown), (unknown), Tim Ahfeldt, Adam Kaplan, Leon M. Ptaszek, Jennifer Walker, Bruce R. Rosengard, Chad A. Cowan	8
16	Efficient Culturing and Genetic Manipulation of Human Pluripotent Stem Cells 2011 ·PLoS ONE ·Robert T. Schinzel, Tim Ahfeldt, Frank H. Lau, Youn‐Kyoung Lee, (unknown), Tony S. Shen, Derek Peters, David H. Lum, Chad A. Cowan	19
17	Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells 2009 ·Nature Genetics ·Sarah Eminli, Adlen Foudi, Matthias Stadtfeld, Nimet Maherali, Tim Ahfeldt, Gustavo Mostoslavsky, Hanno Hock, Konrad Hochedlinger	322
18	Induced pluripotent stem (iPS) cells: an up-to-the-minute review 2009 ·F1000 Biology Reports ·Frank H. Lau, Tim Ahfeldt, Kenji Osafune, (unknown), Chad A. Cowan	7
19	Disease-Specific Induced Pluripotent Stem Cells breakdown → 2008 ·Cell ·In-Hyun Park, Natasha Arora, Hongguang Huo, Nimet Maherali, Tim Ahfeldt, Akiko Shimamura, M. William Lensch, Chad A. Cowan, Konrad Hochedlinger, George Q. Daley	1616
20	A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells 2008 ·Cell stem cell ·Nimet Maherali, Tim Ahfeldt, Alessandra Rigamonti, Jochen Utikal, Chad A. Cowan, Konrad Hochedlinger	426

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact